跳至主要内容
临床试验/CTIS2023-509930-21-00
CTIS2023-509930-21-00进行中(未招募)1 期

PHARMACOKINETICS OF CEFEPIME AFTER INTRAPERITONEAL ADMINISTRATION VIA CYCLER-THERAPY IN APD PATIENTS WITHOUT PERITONITIS - 2

oe LGA Gesundheit Region Mitte GmbH0 个研究点目标入组 8 人开始时间: 2023年12月12日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Males or females over the age of 18, APD regime has to be established for a minimum of 1 month, For short nighttime dwells patient need to use a glucose-based PDF (1,36% and/or 2.27%) and Icodextrin for the long daytime dwell, Preparedness and Compliance to the protocol, Signed informed consent

排除标准

  • Any form of systemic infection, Any disease that might hinder proper study performance or puts the patient at risk, Severe hepatic impairment (Child-Pugh Class C), Severe hepatic impairment (Child-Pugh Class C), Pregnancy or woman of childbearing potential not minded to use appropriate contraception during the time of the study, Allergic or hypersensitive reactions against cephalosporins, Hemoglobin below 9 g/dl, BMI below 19 or above 35

研究者

发起方
oe LGA Gesundheit Region Mitte GmbH

相似试验